Loading insider details...
Latest Form 4 (Jul 7, 2025): Exercise/Conversion of 30 ERNA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 7, 2025 | Ernexa Therapeutics Inc. (ERNA) | Exercise/Conversion | 30 | n/a |
| Feb 10, 2025 | Eterna Therapeutics Inc. (ERNA) | Grant/Award | 150,000 | n/a |
| Jun 25, 2024 | Eterna Therapeutics Inc. (ERNA) | Exercise/Conversion | 437 | n/a |
| Apr 29, 2024 | Eterna Therapeutics Inc. (ERNA) | Grant/Award | 80,000 | n/a |
| Jun 23, 2023 | Eterna Therapeutics Inc. (ERNA) | Exercise/Conversion | 438 | n/a |
| Jun 23, 2022 | Brooklyn ImmunoTherapeutics, Inc. (BTX) | Exercise/Conversion | 8,750 | n/a |
| Mar 15, 2022 | Brooklyn ImmunoTherapeutics, Inc. (BTX) | Grant/Award | 114,500 | n/a |
| Jun 22, 2021 | Brooklyn ImmunoTherapeutics, Inc. (BTX) | Grant/Award | 35,000 | n/a |
| Mar 26, 2021 | Brooklyn ImmunoTherapeutics, Inc. (BTX) | Tax Withholding | 6,094 | $16.3K |
| Mar 22, 2021 | NTN BUZZTIME INC (NTN) | Tax Withholding | 116 | $409.48 |